Preclinical toxicity biomarkers for combination treatment with clotting factors rFXIII and rFVIIa

By Oleksiewicz M. B.   Schaal-Jensen R.   Kiehr B.   Krabbe J. Steenbuch   Sommer C.  

Biomarkers, Vol. 12, Iss. 4, 2007-07 ,pp. : 424-444

Informa Healthcare

Access to resources Recommend Favorite

The Corn Inhibitor of Activated Hageman Factor: Purification and Properties of Two Recombinant Forms of the Protein

By Hazegh-Azam M.   Kim S.S.   Masoud S.   Andersson L.   White F.   Johnson L.   Muthukrishnan S.   Reeck G.  

Protein Expression and Purification, Vol. 13, Iss. 2, 1998-07 ,pp. : 143-149

Academic Press

Access to resources Recommend Favorite

The role of zinc in function of the Rhodobacter sphaeroides anti-sigma factor ChrR

By Donohue T.J.   Anthony J.R.   Newman J.  

Journal of Inorganic Biochemistry, Vol. 96, Iss. 1, 2003-07 ,pp. : 77-77

Elsevier

Access to resources Recommend Favorite

Fucosylation of Complex Glycosphingolipids by Recombinant Fucosyltransferase-VII

By Stroud M.R.   Holmes E.H.  

Biochemical and Biophysical Research Communications, Vol. 238, Iss. 1, 1997-09 ,pp. : 165-168

Elsevier

Access to resources Recommend Favorite

The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution

By Herbert Kirsten E   Prince H Miles   Ritchie David S   Seymour John F  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 1, 2010-01 ,pp. : 113-125

Informa Healthcare

Access to resources Recommend Favorite